Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage



March 29, 2019

Contact: Casey Olesko 973-775-2781 / [email protected]

$8.3 Million in Federal Family Planning Funding for NJ Still Tainted by Trump-Pence Gag Rule

TRENTON, NJ – Yesterday, funding for New Jersey’s network of reproductive health care providers was announced for the next grant period of Title X, the nation’s only program for affordable birth control and other family planning services. This grant period begins on April 1. However, the Trump-Pence administration has placed onerous new restrictions on this funding – the Title X gag rule. This gag rule makes it illegal for health care providers in the Title X program to refer patients for an abortion, and it includes language specifically designed to block patients from coming to Planned Parenthood, threatening their health, their rights, and their lives. Several of these restrictions are set to go into effect on May 3. Because of Planned Parenthood’s commitment to ethical patient care, it would be impossible for Planned Parenthood to continue participating in the program if these rules are put into effect.

“All patients, regardless of income, should have access to the best medical care and information possible,” said Triste Brooks, President and CEO of Planned Parenthood of Northern, Central, and Southern New Jersey. “This gag rule would keep patients from having information about all of their options. We won’t withhold critical information from our patients.”

The Title X gag rule would dismantle the nation’s birth control and reproductive health program. Title X is meant to ensure that people struggling to make ends meet can still access birth control, STI testing, cancer screenings, and other essential reproductive health care. In New Jersey, more than 70 percent of the patients served by Title X received care at a Planned Parenthood health center. Planned Parenthood was the sole Title X provider in 13 New Jersey counties in 2018. Without Planned Parenthood, all other Title X-funded sites in New Jersey would have to increase their contraceptive client caseloads by 254 percent to serve the women who currently obtain birth control from Planned Parenthood health centers.

This rule is opposed by the general public, the medical community, lawmakers, and public health experts. When the rule was announced, nearly 500,000 Americans submitted comments to the U.S. Department of Health and Human Services voicing their opposition. Major medical associations like the American Medical Association, National Medical Association, National Hispanic Medical Association, American College of Obstetricians and Gynecologists, American College of Physicians, and others stand against this rule. In addition, more than 200 members of Congress and 100 public health organizations have come out in opposition to a gag policy.

In fact, earlier this month, Planned Parenthood and the American Medical Association sued President Trump to stop his dangerous gag rule, which threatens the health care of 4 million people in Title X, our nation’s program for affordable birth control and reproductive health care. A second lawsuit was also filed to challenge the rule by 21 state Attorneys General, including New Jersey Attorney General Gurbir Grewal.


This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of our Necessary Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.